APOE and Alzheimer disease: We hypothesize that known AD-related factors (e.g., APOE ε4, age) will show increased p-tau217 and lower Aβ42/Aβ40, whereas non-AD related plasma factors (e.g., kidney function) may show broad increases or broad decreases across all analytes.